BRAEBURN INC.

BRIXADI

Manufacturer:

BRAEBURN INC.

Brixadi HCPCS:

C9154

HCPCS Code Descriptor:

Injection, buprenorphine extended-release (brixadi), 1 mg

Category:

C Code

Brixadi NDCs:

Primary Type:

Opiod Abuse

Generic/Specialty Status:

Single-Source

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Brixadi:

BRIXADI is an Opiod Abuse drug manufactured by Braeburn and administered via the subcutaneous route of administration. The C Code: C9154 is aligned to the drug BRIXADI.

ACCESS PRICING AND MORE BY REGISTERING

C9154 Added Date:

October 1, 2023

C9154 Effective Date:

October 1, 2023

C9154 Termination Date:

December 31, 2023

Brixadi billing and coding information can be found through Braeburn Inc. at the link below:
Brixadi patient assistance information can be found through Braeburn Pharmaceuticals at the URL: https://www.brixadi.com/
BRIXADI prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for BRIXADI. Please check back in a few weeks.